Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1.
Examining pedestrian injuries in motor vehicle accidents: epidemiology and outcome analysis
Epidemiology of head injuries in pedestrian-motor vehicle accidents.